<DOC>
	<DOCNO>NCT01428882</DOCNO>
	<brief_summary>Nonanesthesiologist administration propofol sedation actually field grow interest endoscopists , demonstrate recent American European guideline issue . Propofol hypnotic drug rapid onset offset action . Used single agent , commonly titrate deep sedation , whereas balance propofol sedation ( BPS ) , combine propofol small dos benzodiazepine and/or opioid , successfully titrate moderate sedation . However , nonanesthesiologists propofol administration remain controversial account possibility deep sedation/general anesthesia related adverse event . On hand , use long elimination half-life drug , opioids benzodiazepine , may theoretically prolong sedation recovery . Up date , study address head-to-head comparison regimen administer non-anesthesiologists titrated moderate sedation . This study aim evaluate impact propofol sedation premedication fix dose midazolam ( 2 mg ) 2 minute propofol administration target moderate sedation , term depth sedation , recovery time , safety satisfaction . The onset sedative action midazolam report 1-2.5 minute peak effect midazolam occur 8-12 minute . Taking account colonoscopy usually last minimum 15-20 minute , hypothesis synergy propofol midazolam may increase depth sedation initial phase procedure , diminish propofol requirement , prolong significantly recovery time .</brief_summary>
	<brief_title>Propofol vs. Midazolam-based Balanced Propofol Nonanesthesiologist Moderate Sedation Colonoscopy</brief_title>
	<detailed_description>Justification study : Nonanesthesiologist administration propofol controversial owe deep sedation concern . One late therapeutic innovation issue development balance propofol sedation , consist add low dos opioids benzodiazepins . Several study recently demonstrate BPS allow successfully moderate sedation , maintain reversible drug component , reduces total dose propofol even 50 % without increase adverse event maintain high level physician patient satisfaction , even advance endoscopic procedure . However , recovery may prolong use midazolam meperidine long elimination half-life propofol . Up date , nonanesthesiologist administration propofol BPS , use either midazolam fentanyl , outpatient colonoscopy compare single non-placebo control randomize trial ( VanNatta Rex , 2006 ) . In study , author obtain short recovery time BPS compare propofol alone , contrast expect account pharmacokinetics . These result easily understood yet single-agent propofol titrate deep sedation , whereas BPS titrate moderate sedation . Therefore , necessary make randomize , double-blinded , placebo-controlled trial directly compare sedation regimen target similar moderate level sedation . The result study conclude first line treatment moderate sedation colonoscopy , provide insight drug synergy impact depth sedation recovery time</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>All patient undergo elective outpatient colonoscopy Age le 18 year Allergy propofol , soybean , egg midazolam Chronic intake benzodiazepine History colorectal surgery ASA class IV , short tick neck , difficult intubation due inability open mouth widely Pregnancy Refusal , inability unwillingness give write consent Patients schedule advanced therapeutic colonoscopy one endoscopic procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Propofol</keyword>
	<keyword>Midazolam</keyword>
	<keyword>Moderate sedation</keyword>
	<keyword>Deep sedation</keyword>
	<keyword>Colonoscopy</keyword>
</DOC>